ArticleTobacco induced diseases2026
Secondhand smoke exposure during pregnancy: Nicotine metabolites in maternal urine and breast milk as biomarkers of infant birth weight and length, a cross-sectional study.
Article in Tobacco induced diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionExposure to secondhand smoke (SHS) during pregnancy (P-SHS) has adverse effects on breast milk composition and infant birth outcomes. However, evidence clarifying the exact relationship between nicotine exposure and specific infant outcomes is currently limited. This study aims to explore the association between nicotine metabolite levels - in the urine and breast milk of mothers exposed to SHS - and infant birth weight and length, as well as to assess how P-SHS-related variables modify exposure risk.
methodsThis study was a cross-sectional study of first pregnancies from April to December 2025 in an urban low-income community in Bangkok, Thailand. This study used multi-stage purposive sampling to recruit pregnant women and their infants who were highly exposed to secondhand smoke. Nicotine metabolites were measured in mothers' third-trimester urine and post-delivery breast milk samples, and infants' birth weight and length were measured at the participants' households. All measurements were done after participants provided written consent and had answered the questionnaire. Multiple linear regression was used to assess the association between maternal nicotine metabolites and infant birth outcomes and between P-SHS exposure and participant nicotine levels.
resultsThis study involved 95 pregnant participants exposed to household smoking and their 95 infants. Prenatal maternal urine nicotine metabolite level was significantly associated with breast milk nicotine concentration (p<0.001). Infant weight (p=0.048) and length (p=0.034) were significantly associated with prenatal maternal urine nicotine metabolite levels. Several P-SHS variables reflecting greater SHS exposure, such as smoking in the living room and bedroom (p<0.01), were significantly associated with higher nicotine metabolite levels in prenatal maternal urine.
conclusionsPrenatal P-SHS exposure elevated nicotine metabolite concentrations in maternal urine and breast milk, which were significantly associated with infant birth weight and length.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.